Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities    
Net loss $ (2,087,981) $ (2,596,215)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 372,445 379,375
Impairment loss   1,607,797
Deferred income taxes, net 12 (14,458)
Gain (loss) on derivatives (22,534) 8,294
Loss on extinguishment of debt 601,539 5,014
Provision for bad debts and inventory obsolescence 7,211 10,359
Gain on involuntary conversion of assets (1,817) (1,403)
Share-based compensation expense 49,052 55,147
Net foreign currency adjustments (3,767) 160
Changes in operating assets and liabilities:    
Accounts receivable, net (408,120) (2,108)
Inventories (9,956) 11,996
Prepaid expenses and other assets (242,642) (115,066)
Accounts payable 26,205 369,519
Accrued expenses and other liabilities 46,689 (202,547)
Advance ticket sales 191,609 (844,244)
Net cash used in operating activities (1,482,055) (1,328,380)
Cash flows from investing activities    
Additions to property and equipment, net (309,481) (725,477)
Cash paid on settlement of derivatives (8,559) (28,606)
Other 2,825 2,519
Net cash used in investing activities (315,215) (751,564)
Cash flows from financing activities    
Repayments of long-term debt (879,679) (207,863)
Proceeds from long-term debt 1,223,110 3,962,655
Common share issuance proceeds, net 1,558,396 441,935
Proceeds from employee related plans 1,089 4,100
Net share settlement of restricted share units (16,658) (15,318)
Early redemption premium (611,164)  
Deferred financing fees (28,166) (94,559)
Net cash provided by financing activities 1,246,928 4,090,950
Effect of exchange rates on cash and cash equivalents   (3,933)
Net increase (decrease) in cash and cash equivalents (550,342) 2,007,073
Cash and cash equivalents at beginning of period 3,300,482 252,876
Cash and cash equivalents at end of period $ 2,750,140 $ 2,259,949